Abstract:The use of TNF-α inhibitors for the treatment of moderate to severe
psoriasis and psoriatic arthritis is increasingly more frequent. The authors
report a case of Guillain-Barré syndrome as a late manifestation of the
treatment with adalimumab. Although unusual, this is relevant for professionals
who prescribe biologic drugs. We also stress the importance of investigating the
past and family medical history regarding demyelinating diseases before starting
treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.